Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

BioMed Central full text link BioMed Central Free PMC article
Full text links

Actions

Share

Review
.2019 Dec 23;20(1):117.
doi: 10.1186/s10194-019-1066-0.

Mechanisms of migraine as a chronic evolutive condition

Affiliations
Review

Mechanisms of migraine as a chronic evolutive condition

Anna P Andreou et al. J Headache Pain..

Abstract

Understanding the mechanisms of migraine remains challenging as migraine is not a static disorder, and even in its episodic form migraine remains an "evolutive" chronic condition. Considerable progress has been made in elucidating the pathophysiological mechanisms of migraine, associated genetic factors that may influence susceptibility to the disease, and functional and anatomical changes during the progression of a migraine attack or the transformation of episodic to chronic migraine. Migraine is a life span neurological disorder that follows an evolutive age-dependent change in its prevalence and even clinical presentations. As a disorder, migraine involves recurrent intense head pain and associated unpleasant symptoms. Migraine attacks evolve over different phases with specific neural mechanisms and symptoms being involved during each phase. In some patients, migraine can be transformed into a chronic form with daily or almost daily headaches. The mechanisms behind this evolutive process remain unknown, but genetic and epigenetic factors, inflammatory processes and central sensitization may play an important role.

PubMed Disclaimer

Conflict of interest statement

N/A.

Figures

Fig. 1
Fig. 1
Migraine is cyclic disorders with a complex sequence of symptoms within every headache attack. In its episodic form, migraine is characterised by recurrent attacks involving different phases, with a complex sequence of symptoms within every phase. Significant advances have been made in characterising migraine as a brain disorder and in identifying evolutive functional changes in different brain areas during the different phases of a migraine attack
Fig. 2
Fig. 2
Migraine pathophysiology involves activation of the hypothalamic region during the early premonitory phase, and activation of the trigeminal system during the headache phase. Cortical spreading depression (CSD) is thought to be the biological process of the migraine aura. How activation of the hypothalamus may lead to the development of CSD and activation of the trigeminal system remains unknown. Potentially the hypothalamus may activate direct or indirect pathways involving other brain areas, such us the brainstem, or the parasympathetic system, leading to the development of migraine aura and activation of the ascending trigeminothalamic pathway
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003;23(7):519–527. doi: 10.1046/j.1468-2982.2003.00568.x. - DOI - PubMed
    1. Srikiatkhachorn A, Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache. 1997;37(5):277–280. doi: 10.1046/j.1526-4610.1997.3705277.x. - DOI - PubMed
    1. Karbowniczek A, Domitrz I. Frequency and clinical characteristics of chronic daily headache in an outpatient clinic setting. Neurol Neurochir Pol. 2011;45(1):11–17. doi: 10.1016/S0028-3843(14)60054-2. - DOI - PubMed
    1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349. doi: 10.1212/01.wnl.0000252808.97649.21. - DOI - PubMed
    1. WHO . The global burden of disease. Geneva: World Health Organization; 2004.

Publication types

MeSH terms

Related information

LinkOut - more resources

Full text links
BioMed Central full text link BioMed Central Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp